Home LiteratureArticle Details
PMID: 12124406 Published · ppublish English Case Reports Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Osteoprotegerin deficiency and juvenile Paget's disease.

The New England journal of medicine ·Vol. 347 ·No. 3 ·2002-07-18 ·Pages 175-84

Whyte MP, Obrecht SE, Finnegan PM, Jones JL, Podgornik MN, McAlister WH, Mumm S

Abstract

Juvenile Paget's disease, an autosomal recessive osteopathy, is characterized by rapidly remodeling woven bone, osteopenia, fractures, and progressive skeletal deformity. The molecular basis is not known. Osteoprotegerin deficiency could explain juvenile Paget's disease because osteoprotegerin suppresses bone turnover by functioning as a decoy receptor for osteoclast differentiation factor (also called RANK ligand). We evaluated two apparently unrelated Navajo patients with juvenile Paget's disease for defects in the gene encoding osteoprotegerin (TNFRSF11B) using polymerase-chain-reaction (PCR) amplification followed by direct sequencing and Southern blotting of genomic DNA. Genetic markers near TNFRSF11B were evaluated by both a PCR method that involved sequence-tagged site-content mapping of a deletion of TNFRSF11B and PCR spanning the DNA break points. Both patients had a homozygous deletion of TNFRSF11B, with identical break points, on chromosome 8q24.2. The defect spans approximately 100 kb, but neighboring genes are intact. We found that serum levels of osteoprotegerin and soluble osteoclast differentiation factor were undetectable and markedly increased, respectively. Juvenile Paget's disease can result from osteoprotegerin deficiency caused by homozygous deletion of TNFRSF11B.

MeSH Terms
Adolescent Adult Carrier Proteins/blood,physiology Chromosomes, Human, Pair 8/genetics Fatal Outcome Female Gene Deletion Genetic Markers Glycoproteins/blood,deficiency,genetics,physiology Homozygote Humans Infant Male Membrane Glycoproteins/blood,physiology Molecular Sequence Data Osteitis Deformans/genetics Osteoprotegerin Polymerase Chain Reaction RANK Ligand Receptor Activator of Nuclear Factor-kappa B Receptors, Cytoplasmic and Nuclear/blood,deficiency,genetics,physiology Receptors, Tumor Necrosis Factor/deficiency,genetics,physiology Signal Transduction
Chemicals
Carrier Proteins Genetic Markers Glycoproteins Membrane Glycoproteins Osteoprotegerin RANK Ligand Receptor Activator of Nuclear Factor-kappa B Receptors, Cytoplasmic and Nuclear Receptors, Tumor Necrosis Factor TNFRSF11A protein, human TNFRSF11B protein, human TNFSF11 protein, human
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Whyte Michael P
Center for Metabolic Bone Disease and Molecular Research, Shriners Hospitals for Children, St. Louis, MO 63131, USA. [email protected]
Obrecht Sara E
Finnegan Patrick M
Jones Jonathan L
Podgornik Michelle N
McAlister William H
Mumm Steven
Article Info
Journal
The New England journal of medicine
Abbr.
N Engl J Med
ISSN
1533-4406
Published
2002-07-18
Pages
175-84
Language
English
Region
United States
NLM ID
0255562
Subset
IM
Grants
NIAMS NIH HHS · AR45968 · United States
NICHD NIH HHS · HD33013 · United States
Databases
GENBANK
AB008821, AB008822
Corrections
CommentIn
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]